These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 25006242)
21. Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators. Chandrasekaran C; Coopersmith CM; Gordon JI J Biol Chem; 1996 Nov; 271(45):28414-21. PubMed ID: 8910466 [TBL] [Abstract][Full Text] [Related]
31. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels. Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454 [TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 expression is regulated by the retinoblastoma protein. Müller H; Lukas J; Schneider A; Warthoe P; Bartek J; Eilers M; Strauss M Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2945-9. PubMed ID: 8159685 [TBL] [Abstract][Full Text] [Related]
33. A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells. Camarda G; Siepi F; Pajalunga D; Bernardini C; Rossi R; Montecucco A; Meccia E; Crescenzi M J Cell Biol; 2004 Nov; 167(3):417-23. PubMed ID: 15520231 [TBL] [Abstract][Full Text] [Related]
34. NMR and mass spectrometry studies of putative interactions of cell cycle proteins pRb and CDK6 with cell differentiation proteins MyoD and ID-2. Smialowski P; Singh M; Mikolajka A; Majumdar S; Joy JK; Nalabothula N; Krajewski M; Degenkolbe R; Bernard HU; Holak TA Biochim Biophys Acta; 2005 Jun; 1750(1):48-60. PubMed ID: 15878699 [TBL] [Abstract][Full Text] [Related]
35. JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle. Adhikari A; Mainali P; Davie JK J Biol Chem; 2019 Dec; 294(51):19451-19464. PubMed ID: 31578284 [TBL] [Abstract][Full Text] [Related]
36. Hypoxia inhibits myogenic differentiation through accelerated MyoD degradation. Di Carlo A; De Mori R; Martelli F; Pompilio G; Capogrossi MC; Germani A J Biol Chem; 2004 Apr; 279(16):16332-8. PubMed ID: 14754880 [TBL] [Abstract][Full Text] [Related]
37. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Bailey P; Downes M; Lau P; Harris J; Chen SL; Hamamori Y; Sartorelli V; Muscat GE Mol Endocrinol; 1999 Jul; 13(7):1155-68. PubMed ID: 10406466 [TBL] [Abstract][Full Text] [Related]
38. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032 [TBL] [Abstract][Full Text] [Related]
39. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707 [TBL] [Abstract][Full Text] [Related]
40. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]